Replies to post #418147 on Amarin Corp Plc (AMRN)

[lizzy241]

jasbg, wtf why didn't amarin PR this tweet?

We're thrilled to congratulate our partners, Eddingpharm, who have received confirmation that China’s NMPA has accepted its marketing application for a potential Cardiovascular Risk Reduction (CVRR) indication for VASCEPA (icosapent ethyl).

— Amarin (@Amarincorp) November 16, 2023